🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesGLP-1 and uric acid reduction — gout prevention implications Page 4

GLP-1 and uric acid reduction — gout prevention implications

Dr.RheumBOS Thu, Jun 4, 2026 at 10:10 AM 19 replies 361 viewsPage 4 of 4
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Jun 7, 2026 at 12:11 AM#16
PharmHunterJen said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Mine went the same way, slower. The detail I would add is minor and it is already implied above.

Last edited: Jun 7, 2026 at 4:11 AM
47 22NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 44 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Jun 7, 2026 at 9:56 AM#17

One concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Last edited: Jun 7, 2026 at 1:56 PM
46 21raj_cambridge, ingrid_STO, pete_nash and 43 others
Reply Quote Save Share Report
wanda_boise
Member
412
1,890
Aug 2024
Boise, ID
Jun 7, 2026 at 7:41 PM#18

A narrower follow-up, since the general answer is now clear:

Was that from a primary source or from a summary of one?

Last edited: Jun 8, 2026 at 12:41 AM
45 20pam_columbus, nick_SD_fit, ben_calgary and 42 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Jun 8, 2026 at 5:27 AM#19
hank_denver said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

Last edited: Jun 8, 2026 at 10:27 AM
44 19AussieAnna, BethLabQueen, ChrisMacros and 41 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 8, 2026 at 3:13 PM#20

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Thread quality here is what the rules are for. Keep it up.

Last edited: Jun 8, 2026 at 5:13 PM
22 22PurityPaulOR, MaxMetOK, MounjBrad and 19 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register